A Cornell-led collaboration devised a potentially low-cost method for producing antibodies for therapeutic treatments: bioengineered bacteria with an overlooked enzyme that can help monoclonal antibodies boost their immune defenses.
At the Cornell Thought Summit, Everyday AI & Mental Health: Navigating a Tipping Point, experts gathered to discuss the use of artificial intelligence to improve mental health care for patients.
Cornell Tech researchers unveiled a robot that helps emergency room teams locate life-saving supplies faster, revealing how design can shape collaboration under pressure.
COVID-19 prevention methods such as masking and social distancing also suppressed the circulation of common respiratory diseases, leaving young children lacking immunity to pathogens they otherwise would have been exposed to, a new study reveals.
The new Startup Cornell podcast episode features Van Hamilton Barbeau '11, MS/MBA '20, AVP at Ochsner Ventures, the venture capital arm of Ochsner Health.
Cornell Human Ecology professor Sander Kersten examines sustainable health management strategies in the Nutrition for Metabolic Health eCornell certificate program.
Imprint, an organization founded at Cornell Tech that is dedicated to decoding the body’s immune memory and uncovering the causes of chronic diseases, announced that it has raised over $15 million in funding.
Researchers developed machine-learning models that can sift through cell-free RNA and identify key biomarkers for chronic fatigue syndrome, a debilitating disease that is difficult to confirm in patients because its symptoms can be easily confused with those of other illnesses.